Basket | Login


Philippe Amouyel (France)


Philippe Amouyel, MD, PhD, is Professor of Epidemiology and Public Health at the University Hospital of Lille in Northern France. He heads a large academic research unit working on public health and the molecular epidemiology of aging diseases. His research is focused on the study of determinants, mainly genetic, of neurodegenerative diseases associated with cognitive decline and of Alzheimer's disease in particular. He develops large epidemiological studies to attempt to decode susceptibility to ageing diseases, using molecular techniques such as high-throughput genomics, transcriptomics, proteomics, and bioinformatics. This resulted in his discovery of genetic loci predisposing to sporadic Alzheimer’s disease from a large European, genome-wide association study. This work was extended worldwide through a unique and major international collaboration, the IGAP (International Genomic Alzheimer Project). He published more than 700 original articles and reviews in international journals and participated in the discovery of 24 of the 26 genetic loci predisposing to sporadic Alzheimer's disease known today. Since 2008, he has been the General Director of the National Foundation for Scientific Cooperation on Alzheimer's disease and related disorders (Fondation Alzheimer), a private French non-profit foundation dedicated to supporting innovative, cutting-edge research that will lead to improved prevention, diagnosis, treatment, and patient care for Alzheimer’s disease and related disorders. In addition, Philippe Amouyel chairs the EU Joint Programme on Neurodegenerative Diseases research (JPND), a 30-country initiative (including Canada and Australia) aimed at tackling the challenge of neurodegenerative diseases, in particular Alzheimer's disease at a global level.



Last Updated: Monday 09 July 2018